Global Neurological Biomarker Market Research Report 2016

September 2016 | 118 pages | ID: G534C5016B8EN
QYResearch

Abstracts

Notes:

Production, means the output of Neurological Biomarker

Revenue, means the sales value of Neurological Biomarker

This report studies Neurological Biomarker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Myriad RBM
• Proteome Sciences
• QIAGEN
• Thermo Fisher Scientific
• AbaStar MDx
• Abiant
• Acumen Pharmaceuticals
• Aepodia
• Alseres Pharmaceuticals
• Athena Diagnostics
• Banyan Biomarkers
• Cisbio Bioassays
• Diagenic
• Proteosys
• Psynova Neurotech

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Neurological Biomarker in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Neurological Biomarker in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Neurological Biomarker Market Research Report 2016

1 NEUROLOGICAL BIOMARKER MARKET OVERVIEW

1.1 Product Overview and Scope of Neurological Biomarker
1.2 Neurological Biomarker Segment by Type
  1.2.1 Global Production Market Share of Neurological Biomarker by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Neurological Biomarker Segment by Application
  1.3.1 Neurological Biomarker Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Neurological Biomarker Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Neurological Biomarker (2011-2021)

2 GLOBAL NEUROLOGICAL BIOMARKER MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neurological Biomarker Production and Share by Manufacturers (2015 and 2016)
2.2 Global Neurological Biomarker Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Neurological Biomarker Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Neurological Biomarker Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neurological Biomarker Market Competitive Situation and Trends
  2.5.1 Neurological Biomarker Market Concentration Rate
  2.5.2 Neurological Biomarker Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEUROLOGICAL BIOMARKER PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Neurological Biomarker Production by Region (2011-2016)
3.2 Global Neurological Biomarker Production Market Share by Region (2011-2016)
3.3 Global Neurological Biomarker Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NEUROLOGICAL BIOMARKER SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Neurological Biomarker Consumption by Regions (2011-2016)
4.2 North America Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Neurological Biomarker Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NEUROLOGICAL BIOMARKER PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Neurological Biomarker Production and Market Share by Type (2011-2016)
5.2 Global Neurological Biomarker Revenue and Market Share by Type (2011-2016)
5.3 Global Neurological Biomarker Price by Type (2011-2016)
5.4 Global Neurological Biomarker Production Growth by Type (2011-2016)

6 GLOBAL NEUROLOGICAL BIOMARKER MARKET ANALYSIS BY APPLICATION

6.1 Global Neurological Biomarker Consumption and Market Share by Application (2011-2016)
6.2 Global Neurological Biomarker Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEUROLOGICAL BIOMARKER MANUFACTURERS PROFILES/ANALYSIS

7.1 Myriad RBM
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Neurological Biomarker Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Myriad RBM Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Proteome Sciences
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Neurological Biomarker Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Proteome Sciences Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 QIAGEN
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Neurological Biomarker Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 QIAGEN Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Thermo Fisher Scientific
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Neurological Biomarker Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Thermo Fisher Scientific Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 AbaStar MDx
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Neurological Biomarker Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AbaStar MDx Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Abiant
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Neurological Biomarker Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Abiant Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Acumen Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Neurological Biomarker Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Acumen Pharmaceuticals Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Aepodia
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Neurological Biomarker Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Aepodia Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Alseres Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Neurological Biomarker Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Alseres Pharmaceuticals Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Athena Diagnostics
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Neurological Biomarker Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Athena Diagnostics Neurological Biomarker Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Banyan Biomarkers
7.12 Cisbio Bioassays
7.13 Diagenic
7.14 Proteosys
7.15 Psynova Neurotech

8 NEUROLOGICAL BIOMARKER MANUFACTURING COST ANALYSIS

8.1 Neurological Biomarker Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neurological Biomarker

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neurological Biomarker Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROLOGICAL BIOMARKER MARKET FORECAST (2016-2021)

12.1 Global Neurological Biomarker Production, Revenue Forecast (2016-2021)
12.2 Global Neurological Biomarker Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Neurological Biomarker Production Forecast by Type (2016-2021)
12.4 Global Neurological Biomarker Consumption Forecast by Application (2016-2021)
12.5 Neurological Biomarker Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurological Biomarker
Figure Global Production Market Share of Neurological Biomarker by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Neurological Biomarker Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Neurological Biomarker Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Neurological Biomarker Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Neurological Biomarker Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Neurological Biomarker Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Neurological Biomarker Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Neurological Biomarker Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Neurological Biomarker Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Neurological Biomarker Capacity of Key Manufacturers (2015 and 2016)
Table Global Neurological Biomarker Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Neurological Biomarker Capacity of Key Manufacturers in 2015
Figure Global Neurological Biomarker Capacity of Key Manufacturers in 2016
Table Global Neurological Biomarker Production of Key Manufacturers (2015 and 2016)
Table Global Neurological Biomarker Production Share by Manufacturers (2015 and 2016)
Figure 2015 Neurological Biomarker Production Share by Manufacturers
Figure 2016 Neurological Biomarker Production Share by Manufacturers
Table Global Neurological Biomarker Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Neurological Biomarker Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Neurological Biomarker Revenue Share by Manufacturers
Table 2016 Global Neurological Biomarker Revenue Share by Manufacturers
Table Global Market Neurological Biomarker Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Neurological Biomarker Average Price of Key Manufacturers in 2015
Table Manufacturers Neurological Biomarker Manufacturing Base Distribution and Sales Area
Table Manufacturers Neurological Biomarker Product Type
Figure Neurological Biomarker Market Share of Top 3 Manufacturers
Figure Neurological Biomarker Market Share of Top 5 Manufacturers
Table Global Neurological Biomarker Capacity by Regions (2011-2016)
Figure Global Neurological Biomarker Capacity Market Share by Regions (2011-2016)
Figure Global Neurological Biomarker Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Neurological Biomarker Capacity Market Share by Regions
Table Global Neurological Biomarker Production by Regions (2011-2016)
Figure Global Neurological Biomarker Production and Market Share by Regions (2011-2016)
Figure Global Neurological Biomarker Production Market Share by Regions (2011-2016)
Figure 2015 Global Neurological Biomarker Production Market Share by Regions
Table Global Neurological Biomarker Revenue by Regions (2011-2016)
Table Global Neurological Biomarker Revenue Market Share by Regions (2011-2016)
Table 2015 Global Neurological Biomarker Revenue Market Share by Regions
Table Global Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table China Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table India Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Neurological Biomarker Consumption Market by Regions (2011-2016)
Table Global Neurological Biomarker Consumption Market Share by Regions (2011-2016)
Figure Global Neurological Biomarker Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Neurological Biomarker Consumption Market Share by Regions
Table North America Neurological Biomarker Production, Consumption, Import & Export (2011-2016)
Table Europe Neurological Biomarker Production, Consumption, Import & Export (2011-2016)
Table China Neurological Biomarker Production, Consumption, Import & Export (2011-2016)
Table Japan Neurological Biomarker Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Neurological Biomarker Production, Consumption, Import & Export (2011-2016)
Table India Neurological Biomarker Production, Consumption, Import & Export (2011-2016)
Table Global Neurological Biomarker Production by Type (2011-2016)
Table Global Neurological Biomarker Production Share by Type (2011-2016)
Figure Production Market Share of Neurological Biomarker by Type (2011-2016)
Figure 2015 Production Market Share of Neurological Biomarker by Type
Table Global Neurological Biomarker Revenue by Type (2011-2016)
Table Global Neurological Biomarker Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Neurological Biomarker by Type (2011-2016)
Figure 2015 Revenue Market Share of Neurological Biomarker by Type
Table Global Neurological Biomarker Price by Type (2011-2016)
Figure Global Neurological Biomarker Production Growth by Type (2011-2016)
Table Global Neurological Biomarker Consumption by Application (2011-2016)
Table Global Neurological Biomarker Consumption Market Share by Application (2011-2016)
Figure Global Neurological Biomarker Consumption Market Share by Application in 2015
Table Global Neurological Biomarker Consumption Growth Rate by Application (2011-2016)
Figure Global Neurological Biomarker Consumption Growth Rate by Application (2011-2016)
Table Myriad RBM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Myriad RBM Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Myriad RBM Neurological Biomarker Market Share (2011-2016)
Table Proteome Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Proteome Sciences Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Proteome Sciences Neurological Biomarker Market Share (2011-2016)
Table QIAGEN Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table QIAGEN Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure QIAGEN Neurological Biomarker Market Share (2011-2016)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Thermo Fisher Scientific Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific Neurological Biomarker Market Share (2011-2016)
Table AbaStar MDx Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbaStar MDx Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure AbaStar MDx Neurological Biomarker Market Share (2011-2016)
Table Abiant Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abiant Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abiant Neurological Biomarker Market Share (2011-2016)
Table Acumen Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acumen Pharmaceuticals Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Acumen Pharmaceuticals Neurological Biomarker Market Share (2011-2016)
Table Aepodia Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Aepodia Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Aepodia Neurological Biomarker Market Share (2011-2016)
Table Alseres Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alseres Pharmaceuticals Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alseres Pharmaceuticals Neurological Biomarker Market Share (2011-2016)
Table Athena Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Athena Diagnostics Neurological Biomarker Production, Revenue, Price and Gross Margin (2011-2016)
Figure Athena Diagnostics Neurological Biomarker Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurological Biomarker
Figure Manufacturing Process Analysis of Neurological Biomarker
Figure Neurological Biomarker Industrial Chain Analysis
Table Raw Materials Sources of Neurological Biomarker Major Manufacturers in 2015
Table Major Buyers of Neurological Biomarker
Table Distributors/Traders List
Figure Global Neurological Biomarker Production and Growth Rate Forecast (2016-2021)
Figure Global Neurological Biomarker Revenue and Growth Rate Forecast (2016-2021)
Table Global Neurological Biomarker Production Forecast by Regions (2016-2021)
Table Global Neurological Biomarker Consumption Forecast by Regions (2016-2021)
Table Global Neurological Biomarker Production Forecast by Type (2016-2021)
Table Global Neurological Biomarker Consumption Forecast by Application (2016-2021)